745
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Vascular calcification progression and its association with mineral and bone disorder in kidney transplant recipients

, , , , , , , , , & show all
Article: 2276382 | Received 07 Jul 2023, Accepted 23 Oct 2023, Published online: 07 Nov 2023

References

  • Naylor KL, Li AH, Lam NN, et al. Fracture risk in kidney transplant recipients: a systematic review. Transplantation. 2013;95(12):1–9. doi: 10.1097/TP.0b013e31828eead8.
  • Nair SS, Lenihan CR, Montez-Rath ME, et al. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014;14(4):943–951. doi: 10.1111/ajt.12652.
  • Cianciolo G, Capelli I, Angelini ML, et al. Importance of vascular calcification in kidney transplant recipients. Am J Nephrol. 2014;39(5):418–426. doi: 10.1159/000362492.
  • Benjamens S, Pol RA, Glaudemans A, et al. A high abdominal aortic calcification score by dual X-ray absorptiometry is associated with cardiovascular events after kidney transplantation. Nephrol Dial Transplant. 2018;33(12):2253–2259. doi: 10.1093/ndt/gfy158.
  • Roe P, Wolfe M, Joffe M, et al. Inflammation, coronary artery calcification and cardiovascular events in incident renal transplant recipients. Atherosclerosis. 2010;212(2):589–594. doi: 10.1016/j.atherosclerosis.2010.05.016.
  • Sotomayor CG, Benjamens S, Gomes-Neto AW, et al. Bone mineral density and aortic calcification: evidence for a bone-vascular axis after kidney transplantation. Transplantation. 2021;105(1):231–239. doi: 10.1097/TP.0000000000003226.
  • Gulcicek S, Zoccali C, Olgun DC, et al. Long-term progression of coronary artery calcification is independent of classical risk factors, C-reactive protein, and parathyroid hormone in renal transplant patients. Cardiorenal Med. 2017;7(4):284–294. doi: 10.1159/000475999.
  • Lankinen R, Hakamaki M, Hellman T, et al. Progression of aortic calcification in stage 4-5 chronic kidney disease patients transitioning to dialysis and transplantation. Kidney Blood Press Res. 2022;47(1):23–30. doi: 10.1159/000518670.
  • Seifert ME, Hruska KA. The Kidney-Vascular-Bone axis in the chronic kidney Disease-Mineral bone disorder. Transplantation. 2016;100(3):497–505. doi: 10.1097/TP.0000000000000903.
  • Thompson B, Towler DA. Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol. 2012;8(9):529–543. doi: 10.1038/nrendo.2012.36.
  • Asci G, Ok E, Savas R, et al. The link between bone and coronary calcifications in CKD-5 patients on haemodialysis. Nephrol Dial Transplant. 2011;26(3):1010–1015. doi: 10.1093/ndt/gfq491.
  • Sun L, Wang Z, Zheng M, et al. Mineral and bone disorder after kidney transplantation: a single-center cohort study. Ren Fail. 2023;45(1):2210231. doi: 10.1080/0886022X.2023.2210231.
  • Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study group. Osteoporos Int. 1994;4(6):368–381. doi: 10.1007/BF01622200.
  • He ZX, Hedrick TD, Pratt CM, et al. Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation. 2000;101(3):244–251. doi: 10.1161/01.cir.101.3.244.
  • Jorgensen HS, Behets G, Bammens B, et al. Natural history of bone disease following kidney transplantation. J Am Soc Nephrol. 2022;33(3):638–652. doi: 10.1681/ASN.2021081081.
  • Ferreira AC, Mendes M, Silva C, et al. Improvement of mineral and bone disorders after renal transplantation. Transplantation. 2022;106(5):e251–e261. doi: 10.1097/TP.0000000000004099.
  • Moe SM, O’Neill KD, Reslerova M, et al. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant. 2004;19(9):2387–2393. doi: 10.1093/ndt/gfh303.
  • Mazzaferro S, Pasquali M, Taggi F, et al. Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation. Clin J Am Soc Nephrol. 2009;4(3):685–690. doi: 10.2215/CJN.03930808.
  • Marechal C, Coche E, Goffin E, et al. Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients. Am J Kidney Dis. 2012;59(2):258–269. doi: 10.1053/j.ajkd.2011.07.019.
  • Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15(11):2857–2867. doi: 10.1097/01.ASN.0000141960.01035.28.
  • Wang XR, Yuan L, Zhang JJ, et al. Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D. Nephrology. 2017;22(4):286–292. doi: 10.1111/nep.12813.
  • Shanahan CM, Crouthamel MH, Kapustin A, et al. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109(6):697–711. doi: 10.1161/CIRCRESAHA.110.234914.
  • Naganuma T, Takemoto Y, Uchida J, et al. Hypercalcemia is a risk factor for the progression of aortic calcification in kidney transplant recipients. Kidney Blood Press Res. 2019;44(4):823–834. doi: 10.1159/000501740.
  • Yamamoto D, Suzuki S, Ishii H, et al. Predictors of abdominal aortic calcification progression in patients with chronic kidney disease without hemodialysis. Atherosclerosis. 2016;253:15–21. doi: 10.1016/j.atherosclerosis.2016.08.004.
  • Meneghini M, Regalia A, Alfieri C, et al. Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. Transplantation. 2013;96(1):42–48. doi: 10.1097/TP.0b013e3182934cee.
  • Shroff RC, McNair R, Skepper JN, et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol. 2010;21(1):103–112. doi: 10.1681/ASN.2009060640.
  • Bleskestad IH, Bergrem H, Leivestad T, et al. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transplant. 2014;28(4):479–486. doi: 10.1111/ctr.12341.
  • Yilmaz MI, Sonmez A, Saglam M, et al. A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation. Clin J Am Soc Nephrol. 2015;10(3):471–479. doi: 10.2215/CJN.07860814.
  • de Boer IH, Kestenbaum B, Shoben AB, et al. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009;20(8):1805–1812. doi: 10.1681/ASN.2008111157.
  • Nguyen PT, Coche E, Goffin E, et al. Prevalence and determinants of coronary and aortic calcifications assessed by chest CT in renal transplant recipients. Am J Nephrol. 2007;27(4):329–335. doi: 10.1159/000102978.
  • Bargnoux AS, Vetromile F, Kuster N, et al. Markers of bone remodeling are associated with arterial stiffness in renal transplanted subjects. J Nephrol. 2015;28(6):765–772. doi: 10.1007/s40620-015-0201-5.
  • Zhao Y, Guo Y, Jiang Y, et al. Vitamin D suppresses macrophage infiltration by down-regulation of TREM-1 in diabetic nephropathy rats. Mol Cell Endocrinol. 2018;473:44–52. doi: 10.1016/j.mce.2018.01.001.
  • Chung S, Kim M, Koh ES, et al. Serum 1,25-dihydroxy­vitamin D better reflects renal parameters than 25-hydoxyvitamin D in patients with glomerular diseases. Int J Med Sci. 2017;14(11):1080–1087. doi: 10.7150/ijms.20452.
  • Chen Z, Sun J, Haarhaus M, et al. Bone mineral density of extremities is associated with coronary calcification and biopsy-verified vascular calcification in living-donor renal transplant recipients. J Bone Miner Metab. 2017;35(5):536–543. doi: 10.1007/s00774-016-0788-1.
  • Cejka D, Weber M, Diarra D, et al. Inverse association between bone microarchitecture assessed by HR-pQCT and coronary artery calcification in patients with end-stage renal disease. Bone. 2014;64:33–38. doi: 10.1016/j.bone.2014.03.048.
  • Malluche HH, Blomquist G, Monier-Faugere M, et al. High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis. J Am Soc Nephrol. 2015;26(10):2534–2544. doi: 10.1681/ASN.2014070686.
  • Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009;20(7):1453–1464. doi: 10.1681/ASN.2008070692.
  • Cseprekal O, Kis E, Degi AA, et al. Bone metabolism and arterial stiffness after renal transplantation. Kidney Blood Press Res. 2014;39(6):507–515. doi: 10.1159/000368461.
  • Pennisi P, Signorelli SS, Riccobene S, et al. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int. 2004;15(5):389–395. doi: 10.1007/s00198-003-1550-9.
  • Ferron M, Hinoi E, Karsenty G, et al. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008;105(13):5266–5270. doi: 10.1073/pnas.0711119105.
  • Chen Z, Qureshi AR, Ripsweden J, et al. Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients. Bone. 2016;92:50–57. doi: 10.1016/j.bone.2016.08.007.
  • Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004;95(6):560–567. doi: 10.1161/01.RES.0000141775.67189.98.
  • Hertig A, Gangadhar T, Kalluri R. Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease. J Mol Cell Cardiol. 2010;48(3):497–503. doi: 10.1016/j.yjmcc.2009.07.022.
  • Cheng SL, Shao JS, Behrmann A, et al. Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells. Arterioscler Thromb Vasc Biol. 2013;33(7):1679–1689. doi: 10.1161/ATVBAHA.113.300647.
  • von Toerne C, Schmidt C, Adams J, et al. Wnt pathway regulation in chronic renal allograft damage. Am J Transplant. 2009;9(10):2223–2239. doi: 10.1111/j.1600-6143.2009.02762.x.
  • Seyahi N, Cebi D, Altiparmak MR, et al. Progression of coronary artery calcification in renal transplant recipients. Nephrol Dial Transplant. 2012;27(5):2101–2107. doi: 10.1093/ndt/gfr558.
  • Schankel K, Robinson J, Bloom RD, et al. Determinants of coronary artery calcification progression in renal transplant recipients. Am J Transplant. 2007;7(9):2158–2164. doi: 10.1111/j.1600-6143.2007.01903.x.